Barry A. Borlaug

53.0k total citations · 37 hit papers
469 papers, 31.2k citations indexed

About

Barry A. Borlaug is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Barry A. Borlaug has authored 469 papers receiving a total of 31.2k indexed citations (citations by other indexed papers that have themselves been cited), including 411 papers in Cardiology and Cardiovascular Medicine, 111 papers in Pulmonary and Respiratory Medicine and 80 papers in Surgery. Recurrent topics in Barry A. Borlaug's work include Cardiovascular Function and Risk Factors (339 papers), Heart Failure Treatment and Management (164 papers) and Pulmonary Hypertension Research and Treatments (87 papers). Barry A. Borlaug is often cited by papers focused on Cardiovascular Function and Risk Factors (339 papers), Heart Failure Treatment and Management (164 papers) and Pulmonary Hypertension Research and Treatments (87 papers). Barry A. Borlaug collaborates with scholars based in United States, Denmark and Czechia. Barry A. Borlaug's co-authors include Margaret M. Redfield, Vojtěch Melenovský, Yogesh N.V. Reddy, Masaru Obokata, David A. Kass, Carolyn S.P. Lam, Richard J. Rodeheffer, Walter J. Paulus, Thomas P. Olson and Rick A. Nishimura and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Barry A. Borlaug

441 papers receiving 30.6k citations

Hit Papers

Pulmonary Hypertension in Heart Failure With Preserved Ej... 2005 2026 2012 2019 2009 2006 2010 2010 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
    2009 987 citations Carolyn S.P. Lam, Richard J. Rodeheffer et al. Journal of the American College of Cardiology profile →
  2. Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension
    2006 787 citations Barry A. Borlaug et al. profile →
  3. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
    2010 780 citations Barry A. Borlaug et al. European Heart Journal profile →
  4. Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
    2010 777 citations Barry A. Borlaug, Carolyn S.P. Lam et al. Circulation Heart Failure profile →
  5. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction
    2017 759 citations Masaru Obokata, Yogesh N.V. Reddy et al. Circulation profile →
  6. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction
    2018 704 citations Yogesh N.V. Reddy, Rickey E. Carter et al. Circulation profile →
  7. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction
    2016 666 citations Sanjiv J. Shah, Dalane W. Kitzman et al. Circulation profile →
  8. Age- and Gender-Related Ventricular-Vascular Stiffening
    2005 620 citations Margaret M. Redfield, Steven J. Jacobsen et al. Circulation profile →
  9. Heart Failure With Preserved Ejection Fraction In Perspective
    2019 540 citations Barry A. Borlaug et al. profile →
  10. Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction
    2010 523 citations Barry A. Borlaug, Thomas P. Olson et al. Journal of the American College of Cardiology profile →
  11. Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction
    2006 503 citations Barry A. Borlaug, Vojtěch Melenovský et al. Circulation profile →
  12. The pathophysiology of heart failure with preserved ejection fraction
    2014 499 citations Barry A. Borlaug profile →
  13. Right heart dysfunction in heart failure with preserved ejection fraction
    2014 462 citations Vojtěch Melenovský, Grace Lin et al. European Heart Journal profile →
  14. Evaluation and management of heart failure with preserved ejection fraction
    2020 403 citations Barry A. Borlaug profile →
  15. Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction
    2016 390 citations Masaru Obokata, Garvan C. Kane et al. Circulation profile →
  16. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
    2015 370 citations Margaret M. Redfield, Barry A. Borlaug et al. profile →
  17. Left Atrial Remodeling and Function in Advanced Heart Failure With Preserved or Reduced Ejection Fraction
    2015 369 citations Vojtěch Melenovský, Margaret M. Redfield et al. Circulation Heart Failure profile →
  18. Pulmonary Hypertension Due to Left Heart Disease
    2012 334 citations Barry A. Borlaug et al. Circulation profile →
  19. Exercise Intolerance in Patients With Heart Failure
    2019 290 citations Barry A. Borlaug et al. Journal of the American College of Cardiology profile →
  20. Heart Failure With Preserved Ejection Fraction
    2023 287 citations Barry A. Borlaug, Sanjiv J. Shah et al. Journal of the American College of Cardiology profile →
  21. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
    2024 284 citations Milton Packer, Michael R. Zile et al. profile →
  22. Heart Failure With Preserved Ejection Fraction
    2023 284 citations Margaret M. Redfield, Barry A. Borlaug profile →
  23. Research Priorities for Heart Failure With Preserved Ejection Fraction
    2020 273 citations Sanjiv J. Shah, Barry A. Borlaug et al. Circulation profile →
  24. Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
    2020 260 citations Yogesh N.V. Reddy, Masaru Obokata et al. Journal of the American College of Cardiology profile →
  25. Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging
    2020 224 citations Barry A. Borlaug et al. profile →
  26. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets
    2022 210 citations Barry A. Borlaug, Dalane W. Kitzman et al. profile →
  27. Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction
    2020 181 citations Masaru Obokata, Yogesh N.V. Reddy et al. JACC Heart Failure profile →
  28. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure
    2021 143 citations Barry A. Borlaug et al. European Journal of Heart Failure profile →
  29. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality
    2021 126 citations Frederik H. Verbrugge, Kazunori Omote et al. European Heart Journal profile →
  30. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
    2024 123 citations Mikhail Kosiborod, Barry A. Borlaug et al. profile →
  31. Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea
    2022 88 citations Yogesh N.V. Reddy, Mads J. Andersen et al. profile →
  32. Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure
    2024 63 citations Christopher M. Kramer, Barry A. Borlaug et al. Journal of the American College of Cardiology profile →
  33. Semaglutide and NT-proBNP in Obesity-Related HFpEF
    2024 47 citations Mark C. Petrie, Barry A. Borlaug et al. Journal of the American College of Cardiology profile →
  34. Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial
    2024 46 citations Barry A. Borlaug, Michael R. Zile et al. Nature Medicine profile →
  35. Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials
    2024 43 citations Barry A. Borlaug, Javed Butler et al. European Heart Journal profile →
  36. Inflammation in Obesity-Related HFpEF
    2024 41 citations Subodh Verma, Mark C. Petrie et al. Journal of the American College of Cardiology profile →
  37. Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting
    2025 14 citations Yogesh N.V. Reddy, Atsushi Tada et al. Circulation profile →

Peers

Barry A. Borlaug
Comparison fields: 5 of 152
  • Cardiology and Cardiovascular Medicine 26.6k
  • Pulmonary and Respiratory Medicine 6.9k
  • Surgery 4.0k
  • Radiology, Nuclear Medicine and Imaging 3.9k
  • Endocrinology, Diabetes and Metabolism 3.3k
Replace Michael R. Zile with:
Michael R. Zile United States
Philip A. Poole‐Wilson United Kingdom
Richard B. Devereux United States
Mihai Gheorghiade United States
Nathaniel Reichek United States
Inder S. Anand United States
Frank Ruschitzka Switzerland
G. Michael Felker United States
Mark H. Drazner United States
Gérard M. London France
Michael R. Zile United States View profile →
Citations per field, relative to Barry A. Borlaug
Barry A. Borlaug · 1×
Citations per year, relative to Barry A. Borlaug
Barry A. Borlaug · 1×

Countries citing papers authored by Barry A. Borlaug

Since Specialization
Citations

This map shows the geographic impact of Barry A. Borlaug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry A. Borlaug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry A. Borlaug more than expected).

Fields of papers citing papers by Barry A. Borlaug

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry A. Borlaug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry A. Borlaug. The network helps show where Barry A. Borlaug may publish in the future.

Co-authorship network of co-authors of Barry A. Borlaug

This figure shows the co-authorship network connecting the top 25 collaborators of Barry A. Borlaug. A scholar is included among the top collaborators of Barry A. Borlaug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry A. Borlaug. Barry A. Borlaug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction
2024 ·Journal of the American College of Cardiology ·Subodh Verma, Javed Butler, Barry A. Borlaug, Melanie J. Davies, Dalane W. Kitzman, Mark C. Petrie, Sanjiv J. Shah, Thomas Jensen, Søren Rasmussen, Cecilia Rönnbäck, Béla Merkely, Evan L. O’Keefe, Mikhail Kosiborod
17
2
The Natural History of Atrial Functional Mitral Regurgitation
2024 ·Journal of the American College of Cardiology ·Jwan A. Naser, (unknown), Tomonari Harada, Héctor I. Michelena, Barry A. Borlaug, Mackram F. Eleid, Grace Lin, Christopher G. Scott, (unknown), Patricia A. Pellikka, Vuyisile T. Nkomo, Sorin V. Pislaru
9
3
Autoimmune Disorders in Heart Failure With Preserved Ejection Fraction
2024 ·JACC Heart Failure ·Atsushi Tada, Shunichi Doi, Tomonari Harada, (unknown), Jwan A. Naser, (unknown), Yogesh N.V. Reddy, Barry A. Borlaug
6
4
Cardiac Function, Haemodynamics, and Valve Competence with Exercise in Patients with Heart Failure with Preserved Ejection Fraction and Mild to Moderate Secondary Mitral Regurgitation
2024 ·European Journal of Heart Failure ·Tomonari Harada, Jwan A. Naser, Atsushi Tada, Shunichi Doi, (unknown), Sorin V. Pislaru, Mackram F. Eleid, Hidemi Sorimachi, Masaru Obokata, Yogesh N.V. Reddy, Barry A. Borlaug
6
5
Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial breakdown →
2024 ·Nature Medicine ·Barry A. Borlaug, Michael R. Zile, Christopher M. Kramer, Seth J. Baum, Karla Hurt, Sheldon E. Litwin, Masahiro Murakami, Ou Yang, (unknown), Milton Packer
46
6
Inflammation in Obesity-Related HFpEF breakdown →
2024 ·Journal of the American College of Cardiology ·Subodh Verma, Mark C. Petrie, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Dalane W. Kitzman, Sanjiv J. Shah, Cecilia Rönnbäck, Steen Z. Abildstrøm, (unknown), Dennis Wolf, Dirk von Lewinski, Małgorzata Lelonek, Vojtěch Melenovský, Michele Senni, Mikhail Kosiborod
41
7
Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF
2024 ·JACC Heart Failure ·Yogesh N.V. Reddy, Peter A. Noseworthy, Barry A. Borlaug, Nancy M. Albert
7
8
Prevalence, Incidence, and Outcomes of Diastolic Dysfunction in Isolated Tricuspid Regurgitation
2024 ·JACC. Cardiovascular imaging ·Jwan A. Naser, Tomonari Harada, Atsushi Tada, Shunichi Doi, Gal Tsaban, Sorin V. Pislaru, Vuyisile T. Nkomo, Christopher G. Scott, (unknown), Mackram F. Eleid, Yogesh N.V. Reddy, Grace Lin, Patricia A. Pellikka, Barry A. Borlaug
5
9
Artificial intelligence-enabled ECG for left ventricular diastolic function and filling pressure
2024 ·npj Digital Medicine ·Eunjung Lee, Saki Ito, William R. Miranda, Francisco López-Jiménez, Garvan C. Kane, Samuel J. Asirvatham, Peter A. Noseworthy, Paul A. Friedman, Rickey E. Carter, Barry A. Borlaug, Zachi I. Attia, Jae K. Oh
36
10
Determinants and prognostic implications of left atrial reverse remodelling after coarctation of aorta repair in adults
2023 ·European Heart Journal - Cardiovascular Imaging ·Alexander C. Egbe, (unknown), William R. Miranda, C. Charles Jain, Heidi M. Connolly, Barry A. Borlaug
4
11
Biatrial Myopathy in Heart Failure with Preserved Ejection Fraction
2023 ·European Journal of Heart Failure ·Kazunori Omote, Hidemi Sorimachi, Masaru Obokata, Frederik H. Verbrugge, Massar Omar, Dejana Popović, Yogesh N.V. Reddy, Sorin V. Pislaru, Patricia A. Pellikka, Barry A. Borlaug
13
12
Clinical Phenogroup Diversity and Multiplicity: Impact on Mechanisms of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction
2023 ·European Journal of Heart Failure ·Kathryn F. Larson, Massar Omar, Hidemi Sorimachi, Kazunori Omote, Alessio Alogna, Dejana Popović, Atsushi Tada, Shunichi Doi, Jwan A. Naser, Yogesh N.V. Reddy, Margaret M. Redfield, Barry A. Borlaug
6
13
Prevalence and incidence of diastolic dysfunction in atrial fibrillation: clinical implications
2023 ·European Heart Journal ·Jwan A. Naser, Eunjung Lee, Christopher G. Scott, (unknown), Patricia A. Pellikka, Grace Lin, Sorin V. Pislaru, Barry A. Borlaug
26
14
Improvement in Renal Function During the Treatment of Acute Decompensated Heart Failure: Relationship With Markers of Renal Tubular Injury and Prognostic Importance
2023 ·Circulation Heart Failure ·(unknown), Juan B. Ivey‐Miranda, Zachary L. Cox, (unknown), Christopher Maulion, Lavanya Bellumkonda, Michael G. Shlipak, Michelle M. Estrella, Barry A. Borlaug, Veena S. Rao, Jeffrey M. Testani
6
15
Lung Congestion in Chronic Heart Failure: Haemodynamic, Clinical, and Prognostic Implications
2015 ·European Journal of Heart Failure ·Vojtěch Melenovský, Mads J. Andersen, (unknown), Yogesh N.V. Reddy, Barry A. Borlaug
97
16
A Randomized Pilot Study of Aortic Waveform Guided Therapy in Chronic Heart Failure
2014 ·Journal of the American Heart Association ·Barry A. Borlaug, Thomas P. Olson, (unknown), Vojtěch Melenovský, Vincent L. Sorrell, Kelly Noonan, Grace Lin, Margaret M. Redfield
29
17
Cardiac Output Response to Exercise in Relation to Metabolic Demand in Heart Failure with Preserved Ejection Fraction
2013 ·European Journal of Heart Failure ·Muaz M. Abudiab, Margaret M. Redfield, Vojtěch Melenovský, Thomas P. Olson, David A. Kass, Bruce D. Johnson, Barry A. Borlaug
235
18
Exercise Hemodynamics in Patients With and Without Diastolic Dysfunction and Preserved Ejection Fraction After Myocardial Infarction
2012 ·Circulation Heart Failure ·Mads J. Andersen, Mads Ersbøll, John Bro‐Jeppesen, Finn Gustafsson, Christian Hassager, Lars Køber, Barry A. Borlaug, Søren Boesgaard, (unknown), Jacob Eifer Møller
43
19
Age-Associated Increases in Pulmonary Artery Systolic Pressure in the General Population
2009 ·Circulation ·Carolyn S.P. Lam, Barry A. Borlaug, Garvan C. Kane, Felicity Enders, Richard J. Rodeheffer, Margaret M. Redfield
314
20
Age- and Gender-Related Ventricular-Vascular Stiffening breakdown →
2005 ·Circulation ·Margaret M. Redfield, Steven J. Jacobsen, Barry A. Borlaug, Richard J. Rodeheffer, David A. Kass
620

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael R. Zile Breakdown of academic impact, for papers by Philip A. Poole‐Wilson Breakdown of academic impact, for papers by Richard B. Devereux Breakdown of academic impact, for papers by Mihai Gheorghiade Breakdown of academic impact, for papers by Nathaniel Reichek Breakdown of academic impact, for papers by Inder S. Anand Breakdown of academic impact, for papers by Frank Ruschitzka Breakdown of academic impact, for papers by G. Michael Felker Breakdown of academic impact, for papers by Mark H. Drazner Breakdown of academic impact, for papers by Gérard M. London
Rankless by CCL
2026